Rheumatoid arthritis and the risk of preterm birth-Reference-Cited by-同舟云学术

Rheumatoid arthritis and the risk of preterm birth

Published:2022-12-15 Issue:3 Volume:89 Page:
ISSN:1046-7408
Container-title:American Journal of Reproductive Immunology
language:en
Short-container-title:American J Rep Immunol

Author:

Falcon Robbi Miguel G.¹,Alcazar Renne Margaret U.¹,Mondragon Alric V.²,Penserga Ester G.³,Tantengco Ourlad Alzeus G.⁴

Affiliation:

1. College of MedicineUniversity of the Philippines Manila ManilaPhilippines

2. Division of Allergy and ImmunologyDepartment of MedicineUniversity of the Philippines‐Philippine General Hospital ManilaPhilippines

3. Division of RheumatologyDepartment of MedicineUniversity of the Philippines‐Philippine General Hospital ManilaPhilippines

4. Career Incentive Program Department of Science and Technology ‐ Science Education Institute Taguig Philippines

Publisher

Wiley

Subject

Obstetrics and Gynecology,Reproductive Medicine,Immunology,Immunology and Allergy,Obstetrics and Gynecology,Immunology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/aji.13661

Reference78 articles.

1. Management of rheumatoid arthritis during pregnancy: challenges and solutions;Krause ML;Open Access Rheumatol,2016

2. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies;Guo Q;Bone Res,2018

3. Rheumatoid arthritis

4. Prevalence Trend and Disparities in Rheumatoid Arthritis among US Adults, 2005–2018

5. The prevalence of rheumatic diseases in a Filipino urban population: a WHO‐ILAR COPCORD Study. World Health Organization. International League of Associations for Rheumatology. Community Oriented Programme for the Control of the Rheumatic Diseases;Dans L;J Rheumatol,1997

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mendelian randomization reveals systemic lupus erythematosus and rheumatoid arthritis and risk of adverse pregnancy outcomes;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-02

2. Detection of potential safety signals related to the use of remdesivir and tocilizumab in the COVID era during pregnancy, resorting to open data from the FDA adverse event reporting system (FAERS);Frontiers in Pharmacology;2024-01-31

3. Pregnancy outcomes in women with rheumatoid arthritis: an 11-year French nationwide study;RMD Open;2024-01